Comparative Efficacy of Nonsteroidal Anti-Inflammatory Drugs and Anti-Thromboxane Agents in a Rabbit Adhesion-Prevention Model

References

• Montz FJ, Monk BJ, Lacy SM, Fowler JM. Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug: ability to inhibit post-radical pelvic surgery adhesions in a porcine model. Gynecol Oncol. 1993; 48: 76–79
   PubMedGoogle Scholar
• Orita H, Girgis W, di Zerega GS. Prevention of postsurgical adhesion formation by intraperitoneal administration of ibuprofen. Drug Dev. Res. 1987; 10: 97–105
   Google Scholar
• de Leon FD, Toledo AA, Sanfilippo JS, Yussman MA. The prevention of adhesion formation by nonsteroidal antiinflammatory drugs: an animal study comparing ibuprofen and indomethacin. Fertil Steril. 1984; 41: 639–642
   PubMedGoogle Scholar
• Jarrett JC, Dawood MY. Adhesion formation and uterine tube healing in the rabbit: a controlled study of the effects of ibuprofen and flurbiprofen. Am J Obstet Gynecol. 1986; 155: 1186–1192
   PubMedGoogle Scholar
• Rodgers K, Girgis W, di Zerega GS, Johns DB. Intraperitoneal tolmetin prevents postsurgical adhesion formation in rabbits. Int J Fertil. 1990; 35: 40–45
   PubMedGoogle Scholar
• Menzies D, Ellis H. Intra-abdominal adhesions and their prevention by topical tissue plasminogen activator. JR Soc Med. 1989; 82: 534–535
   PubMedGoogle Scholar
• Rockwell WB, Ehrlich HP. Fibrinolysis inhibition in human bum blister fluid. J Burn Care Rehabil. 1990; 11: 1–6
   PubMedGoogle Scholar
• Ehrlich HP. Anti-inflammatory drugs in the vascular response to burn injury. J Trauma. 1984; 24: 311–318
   PubMedGoogle Scholar
• Lombardino JG. Medicinal chemistry of acidic noristeroidal antiinflammatory drugs. Nonsteroidal Antiinflammatory Druqs, JG Lombardino. Wiley, New York 1985; 253–431
   Google Scholar
• Needleman P, Raz A, Ferrendelli JA, Minkes M. Application of imidazole as a selective inhibitor of thromboxane synthetase in human platelets. Proc Natl Acad Sci USA 1977; 74: 1716–1720
   PubMed Web of Science ®Google Scholar
• Freyne EJ, Raeymaekers A HM, Venet MG, Sipido VK, De Clerck F. Ridogrel. Drugs of the Future 1990; 15: 463–466
   Google Scholar
• LeGrand EK, Rodgers KE, Girgis W, et al. Efficacy of tolmetin sodium for adhesion prevention in rabbit and rat models. J Surg Res. 1994; 56: 67–71
   PubMedGoogle Scholar
• Conover WJ, Iman RL. Rank transformations as a bridge between parametric and nonparametric statistics. Am Statistician 1981; 35: 124–129
   Web of Science ®Google Scholar
• Rodgers KE, Ellefson D, Girgis W, di Zerega GS. Protease and protease inhibitor secretion by postsurgical macrophages following in vitro exposure to tolmetin. Agents Actions 1992; 36: 248–257
   PubMedGoogle Scholar
• Williams JG, Maier RV. Ketoconazole inhibits alveolar macrophage production of inflammatory mediators involved in acute lung injury (adult respiratory distress syndrome). Surgery. 1992; 112: 270–277
   PubMed Web of Science ®Google Scholar
• Fiddler GI, Lumley P. Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers: a review. Circulation 1990; 81((suppl I)), I-69-1-78
   PubMedGoogle Scholar
• Fitz Gerald GA. Mechanisms of platelet activation: thromboxane A, as an amplifying signal for other agonists. Am J Cardiol. 1991; 68: 11B–15B
   Google Scholar
• Steinleitner A, Lambert H, Suarez M, Serpa N, Robin B. Reduction of primary posttraumatic adhesion formation with the prostacyclin analog iloprost in a rodent model. Am J Obstet Gynecol. 1991; 165: 1817–1820
   PubMedGoogle Scholar
• Golan A, Bernstein T, Wexler S, Neuman M, Bukovsky I, David MP. The effect of prostaglandins and aspirin—an inhibitor of prostaglandin synthesis—on adhesion formation in rats. Hum Reprod. 1991; 6: 251–254
   PubMedGoogle Scholar
• de Gaetano G, Cerletti C, Nanni-Costa MP, Pogg A. The blood platelet as an inflammatory cell. Eur Respir J. 1989; 2((suppl 6))441s–445s
   Google Scholar
• Gentry PA. The mammalian blood platelet: its role in haemostasis, inflammation and tissue repair. J Comp Pathol. 1992; 107: 243–270
   PubMedGoogle Scholar
• Bazzoni G, Dejana E, del Maschio A. Platelet-dependent modulation of neutrophil function. Pharmacol Res 1992; 26: 269–272
   PubMedGoogle Scholar
• Page CP. Platelets as inflammatory cells. Immunopharmacology 1989; 17: 51–59
   PubMed Web of Science ®Google Scholar
• Deuel TF, Senior RM, Chang D, Griffin GL, Heinrikson RL, Kaiser E. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U SA 1981; 78: 4584–4587
   PubMed Web of Science ®Google Scholar
• Deuel TF, Senior RM, Huang JS, Griffin GL. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest. 1982; 69: 1046–1049
   PubMed Web of Science ®Google Scholar
• Assoian RK, Komoriya A, Meyers CA, Miller DM, Spom MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification and characterization. J Biol Chem. 1983; 258: 7155–7160
   PubMed Web of Science ®Google Scholar
• Turner SR, Tainer JA, Lynn WS. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature 1975; 257: 680–681
   PubMed Web of Science ®Google Scholar
• Williams RS, Rossi AM, Chegini N, Schultz G. The effect of transforming growth factor beta on postoperative adhesion formation and intact peritoneum. J Surg Res. 1992; 52: 65–70
   PubMed Web of Science ®Google Scholar
• Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987; 84: 5788–5792
   PubMed Web of Science ®Google Scholar
• Longaker MT, Banda MJ, Roberts AB, et al. In vivo response to injected TGF-β isoforms individually and in combinations. J Cell Biochem. 1993; 121, Abstr Suppl 17E
   Google Scholar
• Slivka SR, Loskutoff DJ. Platelets stimulate endothelial cells to synthesize type I plasminogen activator inhibitor: evaluation of the role of transforming growth factor beta. Blood 1991; 77: 1013–1019
   PubMedGoogle Scholar
• Roberts AB, Flanders KC, Kondaiah P, et al. Transforming growth factor p: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Prog Hormone Res. 1988; 44: 157–197
   PubMedGoogle Scholar
• Jang I-K, Gold HK, Ziskind AA, et al. Differential sensitivity of erythrocyterich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: a possible explanation for resistance to coronary thrombolysis. Circulation 1989; 79: 920–928
   PubMed Web of Science ®Google Scholar
• Patrono C. Biosynthesis and pharmacological modulation of thromboxane in humans. Circulation 1990; 81((suppl 1)), I-12-I-15
   Google Scholar
• Neichi T, Tomisawa S, Kubodera N, Uchida Y. Enhancement of PGI, formation by a new vasodilator, 2-nicotinarnidoethyl nitrate in the coupled system of platelets and aortic microsomes. Prostaglandins. 1980; 19: 577–586
   PubMedGoogle Scholar
• Keith JC, Goodrich JA, Endo Y, Taub D, Mehiman P, Ward G. Effects of ridogrel on the prostacyclin-thromboxane ratio in nulliparous third trimester-pregnant rhesus monkeys. Prostaglandins. 1993; 45: 547–555
   PubMedGoogle Scholar